ATR Logo

AptarGroup, Inc. (ATR) 

NYSE
Market Cap
$10.53B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
431 of 960
Rank in Industry
22 of 49

Largest Insider Buys in Sector

ATR Stock Price History Chart

ATR Stock Performance

About AptarGroup, Inc.

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable …

Insider Activity of AptarGroup, Inc.

Over the last 12 months, insiders at AptarGroup, Inc. have bought $0 and sold $28.14M worth of AptarGroup, Inc. stock.

On average, over the past 5 years, insiders at AptarGroup, Inc. have bought $299,504 and sold $15.34M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,170 shares for transaction amount of $299,504 was made by Trerotola Matthew L. (director) on 2022‑11‑03.

List of Insider Buy and Sell Transactions, AptarGroup, Inc.

2024-11-22Saledirector
1,257
0.0019%
$171.64$215,746+0.08%
2024-11-15SaleEVP and Chief Legal Officer
964
0.0014%
$168.83$162,752+2.91%
2024-11-12SaleSegment President
852
0.0013%
$175.79$149,770-2.49%
2024-10-29SaleSegment President
4,000
0.006%
$168.28$673,136+1.67%
2024-10-28SalePresident and CEO
30,000
0.0462%
$169.60$5.09M-0.53%
2024-09-13SaleSegment President
1,375
0.0021%
$152.54$209,745+10.74%
2024-09-09SaleSegment President
3,300
0.005%
$151.62$500,338+10.65%
2024-08-29SaleSegment President
3,500
0.0053%
$152.31$533,085+9.94%
2024-08-26SaleEVP & CFO
1,000
0.0015%
$151.29$151,287+10.88%
2024-08-26SaleChief Human Resources Officer
1,660
0.0025%
$151.15$250,905+10.88%
2024-08-23SaleEVP & CFO
49,463
0.0743%
$149.97$7.42M+10.62%
2024-08-22SaleEVP & CFO
200
0.0003%
$150.18$30,036+11.64%
2024-08-15SalePresident, Asia
7,200
0.0111%
$146.52$1.05M0.00%
2024-08-13Saledirector
1,922
0.0029%
$144.43$277,6030.00%
2024-08-07SalePresident, Asia
800
0.0012%
$146.56$117,252+12.16%
2024-07-29SalePresident and CEO
32,000
0.0482%
$147.56$4.72M+8.23%
2024-06-06SaleEVP and Chief Legal Officer
825
0.0013%
$146.77$121,086+6.83%
2024-05-07SaleSegment President
3,200
0.0048%
$148.92$476,538+1.18%
2024-05-01SaleSegment President
4,634
0.007%
$145.09$672,344+4.04%
2024-03-12Saledirector
2,000
0.003%
$142.45$284,906+4.03%

Insider Historical Profitability

13.88%
Tanda Stephan B.President and CEO
174118
0.2617%
$158.1813+13.88%
CHEVASSUS ALAINdirector
15896
0.0239%
$158.1816+22.89%
Wunderlich Ralf K.director
7465
0.0112%
$158.1815+7.37%
FOTIADES GEORGE Ldirector
4962
0.0075%
$158.1814+7.59%
GOLDSTEIN RODNEY Ldirector
4500
0.0068%
$158.1820+18.82%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.03B10.817.16M+0.07%+$748,084.110.02
BlackRock$877.86M9.216.1M+0.46%+$4.06M0.02
Morgan Stanley$721.29M7.575.01M+1.88%+$13.28M0.05
State Farm$682.7M7.164.74M0%+$00.62
State Street$427.7M4.492.97M-2.7%-$11.87M0.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.